ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
ABVC on Nasdaq
Shares outstanding
17,410,719
Price per share
$2.15
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
785,330
Total reported value
$2,387,168
% of total 13F portfolios
0%
Share change
+417,953
Value change
+$1,270,658
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lind Global Fund II LP 3.2% -67% $2,211,858 -$3,048,392 557,143 -58% Lind Global Fund II LP 30 Jun 2025
Jiang Eugene 18% +6.5% $219,036 131,159 0% Eugene Jiang 10 Jul 2025

As of 30 Sep 2025, 14 institutional investors reported holding 785,330 shares of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC). This represents 4.5% of the company’s total 17,410,719 outstanding shares.

Institutional Holders of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 785,330 $2,387,168 +$1,270,658 $3.04 14
2025 Q2 367,377 $817,414 +$224,883 $2.22 9
2025 Q1 287,497 $304,746 -$34,328 $1.06 10
2024 Q4 409,227 $241,042 +$106,078 $0.59 13
2024 Q3 228,092 $155,858 +$3,065 $0.68 9
2024 Q2 220,365 $170,561 -$121,328 $0.77 10
2024 Q1 254,432 $332,632 +$197,002 $1.31 7
2023 Q4 110,683 $128,503 +$41,982 $1.16 7
2023 Q3 76,762 $79,757 +$79,757 $1.04 8